IPHA

Innate Pharma
IPHA

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$5
159% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Swayampakula Ramakanth
83% 1-yr IPHA win rate
29 Oct ‘25 1 month ago
BTIG
BTIG
Justin Zelin
0% 1-yr IPHA win rate
29 Oct ‘25 1 month ago
Leerink Partners
Leerink Partners
Daina Graybosch
18 Sep ‘25 2 months ago